These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 15673630

  • 1. Validation of the Women's Health Initiative Insomnia Rating Scale in a multicenter controlled clinical trial.
    Levine DW, Dailey ME, Rockhill B, Tipping D, Naughton MJ, Shumaker SA.
    Psychosom Med; 2005; 67(1):98-104. PubMed ID: 15673630
    [Abstract] [Full Text] [Related]

  • 2. Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life.
    Soares CN, Arsenio H, Joffe H, Bankier B, Cassano P, Petrillo LF, Cohen LS.
    Menopause; 2006; 13(5):780-6. PubMed ID: 16894334
    [Abstract] [Full Text] [Related]

  • 3. Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial.
    Soares CN, Joffe H, Rubens R, Caron J, Roth T, Cohen L.
    Obstet Gynecol; 2006 Dec; 108(6):1402-10. PubMed ID: 17138773
    [Abstract] [Full Text] [Related]

  • 4. Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.
    Diem S, Grady D, Quan J, Vittinghoff E, Wallace R, Hanes V, Ensrud K.
    Menopause; 2006 Dec; 13(1):130-8. PubMed ID: 16607109
    [Abstract] [Full Text] [Related]

  • 5. Does hormone therapy improve age-related skin changes in postmenopausal women? A randomized, double-blind, double-dummy, placebo-controlled multicenter study assessing the effects of norethindrone acetate and ethinyl estradiol in the improvement of mild to moderate age-related skin changes in postmenopausal women.
    Phillips TJ, Symons J, Menon S, HT Study Group.
    J Am Acad Dermatol; 2008 Sep; 59(3):397-404.e3. PubMed ID: 18625536
    [Abstract] [Full Text] [Related]

  • 6. Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial.
    Joffe H, Petrillo L, Viguera A, Koukopoulos A, Silver-Heilman K, Farrell A, Yu G, Silver M, Cohen LS.
    Am J Obstet Gynecol; 2010 Feb; 202(2):171.e1-171.e11. PubMed ID: 20035910
    [Abstract] [Full Text] [Related]

  • 7. Perimenopausal women in estrogen vasomotor trials: contribution to placebo effect and efficacy outcome.
    Simon JA, Stevens RE, Ayres SA, Phelps KV.
    Climacteric; 2001 Mar; 4(1):19-27. PubMed ID: 11379374
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vasomotor hot flashes and heart rate variability: a placebo-controlled trial of postmenopausal hormone therapy.
    Lantto H, Haapalahti P, Tuomikoski P, Viitasalo M, Väänänen H, Sovijärvi AR, Ylikorkala O, Mikkola TS.
    Menopause; 2012 Jan; 19(1):82-8. PubMed ID: 21934534
    [Abstract] [Full Text] [Related]

  • 11. Vasomotor hot flushes and 24-hour ambulatory blood pressure in normotensive women: A placebo-controlled trial on post-menopausal hormone therapy.
    Tuomikoski P, Haapalahti P, Sarna S, Ylikorkala O, Mikkola TS.
    Ann Med; 2010 Jul; 42(5):334-43. PubMed ID: 20429800
    [Abstract] [Full Text] [Related]

  • 12. Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial.
    Bachmann GA, Schaefers M, Uddin A, Utian WH.
    Obstet Gynecol; 2007 Oct; 110(4):771-9. PubMed ID: 17906008
    [Abstract] [Full Text] [Related]

  • 13. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women.
    Joffe H, Hall JE, Gruber S, Sarmiento IA, Cohen LS, Yurgelun-Todd D, Martin KA.
    Menopause; 2006 Oct; 13(3):411-22. PubMed ID: 16735938
    [Abstract] [Full Text] [Related]

  • 14. A multicenter, open-label study to evaluate satisfaction and menopausal quality of life in women using transdermal estradiol/norethindrone acetate therapy for the management of menopausal signs and symptoms.
    Adler G, Young D, Galant R, Quinn L, Witchger MS, Maki KC.
    Gynecol Obstet Invest; 2005 Oct; 59(4):212-9. PubMed ID: 15753617
    [Abstract] [Full Text] [Related]

  • 15. Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women.
    Bachmann GA, Schaefers M, Uddin A, Utian WH.
    Menopause; 2009 Oct; 16(5):877-82. PubMed ID: 19458560
    [Abstract] [Full Text] [Related]

  • 16. Pulsed estrogen therapy improves postmenopausal quality of life: a 2-year placebo-controlled study.
    Nielsen TF, Ravn P, Pitkin J, Christiansen C.
    Maturitas; 2006 Jan 20; 53(2):184-90. PubMed ID: 16368471
    [Abstract] [Full Text] [Related]

  • 17. A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women.
    Endrikat J, Graeser T, Mellinger U, Ertan K, Holz C.
    Maturitas; 2007 Oct 20; 58(2):201-7. PubMed ID: 17889463
    [Abstract] [Full Text] [Related]

  • 18. A comparison of the central effects of different progestins used in hormone replacement therapy.
    Cagnacci A, Arangino S, Baldassari F, Alessandrini C, Landi S, Volpe A.
    Maturitas; 2004 Aug 20; 48(4):456-62. PubMed ID: 15283939
    [Abstract] [Full Text] [Related]

  • 19. Continuous combined hormone replacement therapy relieves climacteric symptoms and improves health-related quality of life in early postmenopausal women.
    Pitkin J, Smetnik VP, Vadász P, Mustonen M, Salminen K, Ylikangas S, Indivina 321 Study Group.
    Menopause Int; 2007 Sep 20; 13(3):116-23. PubMed ID: 17785037
    [Abstract] [Full Text] [Related]

  • 20. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.
    Reed SD, Newton KM, LaCroix AZ, Grothaus LC, Grieco VS, Ehrlich K.
    Menopause; 2008 Sep 20; 15(1):51-8. PubMed ID: 18257142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.